Advancing Mobility-Related Activities of Daily Living Monitoring in Parkinson’s Disease: A Systematic Review of Wearable Sensor Technologies
Objective: To systematically review current evidence on wearable sensor devices for the objective monitoring of mobility-related ADLs in patients with PD. Background: Detecting Activities of…Acceptability and feasibility of digital mobility assessment for Parkinson’s Disease: Perspectives from people with Parkinson’s, carers and health and social care professionals in Ghana and Kenya
Objective: To explore perspectives of people with Parkinson’s disease (PD), carers and health and social care professionals (HSCPs) in Ghana and Kenya on the acceptability…Identifying Informative Speech Tasks for Detecting Clinically Relevant Changes in Parkinson’s Disease
Objective: To identify the most informative speech tasks for detecting clinically relevant speech changes in Parkinson’s Disease (PD) and to develop a streamlined, data-driven assessment…Intersectin-1 (ITSN1) Loss-of-Function Variants in Parkinson’s Disease: Clinical Phenotypes and Neuropathological Insights
Objective: To examine the clinical and neuropathological features of carriers of loss-of-function (LoF) variants in ITSN1. Background: Intersectin-1 (ITSN1) is a large multidomain protein involved…Sleep Patterns and Cognitive Function in Parkinson’s Disease: a Longitudinal Pilot Study
Objective: To evaluate the feasibility and usability of a commercially available wearable device for long-term monitoring of sleep patterns in Parkinson’s disease (PD) and how…Brain-First and Body-First Model Translated to Individual-Level Characterization in Parkinson’s Disease: Multimodal Imaging and Clinical Approach
Objective: To determine whether the body-first versus brain-first hypothesis of Parkinson’s disease (PD) can be reliably applied at the individual patient level using multimodal clinical…Caffeine and Tobacco Exposure and the Presence of Levodopa-Induced Dyskinesia (LID) in the STAT-PD Trial
Objective: Using data from the STAT-PD trial, ClinicalTrials NCT # 4064294, we examined whether lifetime caffeine and nicotine exposure are associated with the presence and…Interleaving Deep Brain Stimulation: Achieving Optimal Clinical Outcomes at Lower Per-contact Voltages and Energy Consumption
Objective: - Background: The goal of deep brain stimulation (DBS) is to achieve optimal symptom control while minimizing stimulation-related side effects. Interleaving stimulation offers a…Volumetric Imaging Diagnostic Tool to Differentiate Progressive Supranuclear Palsy from Parkinson’s Disease using Artificial Intelligence
Objective: To develop and evaluate a novel MRI-based volumetric diagnostic index using artificial intelligence–driven segmentation for differentiating progressive supranuclear palsy (PSP) from Parkinson’s disease (PD).…Neuropsychiatric Symptoms in Parkinson’s Disease in Low- and Middle-Income Countries: A Systematic Review
Objective: To assess the prevalence and patterns of neuropsychiatric symptoms among patients with Parkinson’s disease in low- and middle-income countries (LMICs). Background: Neuropsychiatric manifestations such…
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 553
- Next Page »